Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

Nature
Karen F KozarskyMonty Krieger

Abstract

The risk of atherosclerosis, a leading cause of cardiovascular disease and death, is inversely related to plasma levels of high-density lipoprotein (HDL) cholesterol, although the mechanism of this protective effect is unclear. The class B scavenger receptor, SR-BI, is the first HDL receptor to be well defined at a molecular level and is a mediator of selective cholesterol uptake in vitro. It is expressed most abundantly in steroidogenic tissues, where it is coordinately regulated with steroidogenesis by adrenocorticotropic hormone (ACTH), human chorionic gonadotropin (hCG) and oestrogen, and in the liver, where its expression in rats is suppressed by oestrogen. Here we show that adenovirus-mediated, hepatic overexpression of SR-BI in mice on both sinusoidal and canalicular surfaces of hepatocytes results in the virtual disappearance of plasma HDL and a substantial increase in biliary cholesterol. SR-BI may directly mediate these effects by increasing hepatic HDL cholesterol uptake or by increasing cholesterol secretion into bile, or both. These results indicate that SR-BI may be important in hepatic HDL metabolism, in determining plasma HDL concentrations, and in controlling cholesterol concentrations in bile, and thus may inf...Continue Reading

References

Nov 9, 1989·The New England Journal of Medicine·D J Gordon, B M Rifkind
Apr 4, 1986·Science·M S Brown, J L Goldstein
Mar 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N UlloaF Nervi
Nov 21, 1981·British Medical Journal·J R ThorntonD G Macfarlane
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Herz, R D Gerard

❮ Previous
Next ❯

Citations

Jun 11, 2008·Journal of Human Genetics·Yongjun LiuDonna K Arnett
Dec 21, 2000·Current Atherosclerosis Reports·M A KawashiriD J Rader
Dec 21, 2000·Current Atherosclerosis Reports·V S Kamanna, M L Kashyap
Apr 5, 2002·Current Atherosclerosis Reports·Kazuhiro Oka, Lawrence Chan
Jun 14, 2006·Current Atherosclerosis Reports·Atif Qasim, Daniel J Rader
Apr 13, 2011·Current Atherosclerosis Reports·Carlos G Santos-GallegoJuan José Badimón
Dec 21, 2000·Current Atherosclerosis Reports·T Pakkanen, S Ylä-Herttuala
Dec 4, 2003·Biochemical and Biophysical Research Communications·Magnus S C JohnsonBjörn Carlsson
Jun 9, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Maria R Tosi, Vitaliano Tugnoli
Dec 26, 2003·Comptes rendus biologies·Alexandra C ProvostMarc Abitbol
Sep 6, 2003·The American Journal of Cardiology·Daniel J Rader
Feb 16, 1999·Biochimica Et Biophysica Acta·U P Steinbrecher
Mar 13, 2002·Atherosclerosis·Dmitri Sviridov, Paul Nestel
Jul 17, 1999·Atherosclerosis·O Stein, Y Stein
Feb 3, 2000·Mechanisms of Ageing and Development·H ShiraiT Kodama
Feb 16, 2000·Lancet·S Ylä-Herttuala, J F Martin
Mar 23, 2000·Journal of Hepatology·G A Kullak-UblickG Paumgartner
Apr 20, 2001·Advanced Drug Delivery Reviews·P C RensenT J van Berkel
Jul 25, 2000·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·D NdiayeS Hayashi
Apr 9, 2001·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·F MilliatC Lutton
Apr 13, 1999·Gastroenterology Clinics of North America·Z R VlahcevicR T Stravitz
May 4, 2002·The Journal of Nutritional Biochemistry·Murielle M.J. Combettes-SouverainClaude Y. Lutton
Aug 16, 2001·Trends in Endocrinology and Metabolism : TEM·K LuS B Patel
Apr 3, 2003·Chemistry & Biology·David L Williams
Jan 14, 2003·Seminars in Cell & Developmental Biology·Peter Marschang, Joachim Herz
Jul 4, 2001·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·H KatohS Hayashi
Aug 28, 2003·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Jyh-Yih ChenJen-Leih Wu
Nov 1, 2003·The International Journal of Biochemistry & Cell Biology·David Rhainds, Louise Brissette
Oct 26, 1999·The International Journal of Biochemistry & Cell Biology·D Rhainds, L Brissette
Nov 24, 1999·Molecular Medicine Today·S L ActonA Rigotti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.